Prema Cognition is a digital healthtech company focused on earlier detection of dementia. It is the company behind PREMAZ, a digital cognitive assessment created in collaboration with the University of Cambridge Memory Lab. PREMAZ is designed to identify subtle changes in cognitive decline long before symptoms appear. By translating advanced neuroscience into a clinician-ready digital tool, Prema Cognition is enabling earlier intervention and supporting research into brain health. The platform is already in use across clinics and research settings in the UK and US. Prema Cognition was co-founded by medical doctor Dr. Julia Cooney, a Forbes 30 Under 30 honoree and Cameron Kirkpatrick.
Prema Cognition: Venture Capital Funding History
Prema Cognition
Prema Cognition
- Health
- Cambridge, United Kingdom
- £550k
- premaz.org
- Update Information
More venture news
- 30 Sept 2026

Inovus MedicalInovus Medical lands £7m extension led by PXN Group to provide surgeons with surgical simulation training
EquityHealth - 29 Sept 2026

DYADDYAD secures a £7.5m Series A led by Sangha Capital for its system that converts clinical documents into structured data for GP patient records
Series AHealth - 24 Sept 2026

IMS SolutionsIMS Solutions raises a £1.1m seed round led by Midlands Mindforge to develop steroid tests for cancer and PMOS
SeedHealth
